Otofarma SpAMIL:OTO -0.71%16 FCF Margin % is 13.28% as of Dec. 2024, which is 15% above its 10-year median of 11.53. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Otofarma SpA ranks better than 81.1% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Otofarma SpA's Free Cash Flow for the
six
months ended in Dec. 2024 was €2.02 Mil. Otofarma SpA's Revenue for the
six
months ended in Dec. 2024 was €15.20 Mil. Therefore, Otofarma SpA's FCF Margin % for the quarter that ended in Dec. 2024 was 13.28%.
The historical rank and industry rank for Otofarma SpA's FCF Margin % or its related term are showing as below:
MIL:OTO'
s FCF Margin % Range Over the Past 10 Years
Min: 9.77 Med: 11.53 Max: 13.28
Current: 13.28
During the past 2 years, the highest FCF Margin % of Otofarma SpA was 13.28%. The lowest was 9.77%. And the median was 11.53%.
MIL:OTO's FCF Margin % is ranked better than 81.1% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.34
vs MIL:OTO: 13.28
Otofarma SpA FCF Margin % Related Terms
Otofarma SpA FCF Margin % Historical Data
* Premium members only.
The historical data trend for Otofarma SpA's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA FCF Margin % Chart
Otofarma SpA Annual Data
Trend
Dec23
Dec24
FCF Margin %
9.77
13.28
Otofarma SpA Semi-Annual Data
Dec23
Dec24
FCF Margin %
9.77
13.28
MIL:OTO vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Otofarma SpA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otofarma SpA FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Otofarma SpA's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA (MIL:OTO) has a FCF Margin % of 13.28% as of Dec. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Otofarma SpA and its competitors. This is 15% above median its historical median of 11.53. Over the past decade, Otofarma SpA's FCF Margin % has ranged from 9.77 to 13.28. According to the industry distribution chart, Otofarma SpA ranks #154 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 18.9%.
Is Otofarma SpA's FCF Margin % too high?
Otofarma SpA's current FCF Margin % of 13.28% is 15% above median its 10-year median of 11.53. Over the past 10 years, this metric has ranged from a low of 9.77 to a high of 13.28. Based on the distribution chart, Otofarma SpA ranks #154 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Otofarma SpA ranks #154 out of 815 companies for FCF Margin %. This places Otofarma SpA in the top 19% of its industry — outperforming the majority of peers. Historically, Otofarma SpA's own FCF Margin % has ranged from 9.77 to 13.28 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current FCF Margin % is 13.28%, which is 15% above median its own 10-year median of 11.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current FCF Margin % of 13.28%. The current FCF Margin % is 13.28%, which is 15% above median its 10-year median of 11.53. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current FCF Margin % is 13.28% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score
Get the complete analysis for MIL:OTO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:OTO has been successfully added to your 